● Recruiting

Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease

Condition: Parkinson's Disease · Sponsor: AbbVie

PhaseN/A

Planned participants2000

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Main objective of this study is to describe the evolution of infusion settings (base, high and low infusion rates) of foslevodopa/foscarbidopa subcutaneous infusion (LDp/CDp) at different timepoints in the treatment of advanced Parkinson's disease (aPD) as captured in ONE-CRM.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (4)

Medizinische Universitaet Graz /ID# 278569	Graz, Styria, Austria	Not Yet Recruiting
Medisch Spectrum Twente /ID# 276695	Enschede, Overijssel, Netherlands	Recruiting
Universitatea De Medicină Și Farmacie Victor Babeș /ID# 276720	Timișoara, Timiș County, Romania	Recruiting
Karolinska University Hospital Solna /ID# 277116	Solna, Stockholm County, Sweden	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06937034